Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma AL Gomes, A Teijeiro, S Burén, KS Tummala, M Yilmaz, A Waisman, ... Cancer cell 30 (1), 161-175, 2016 | 331 | 2016 |
Inhibition of de novo NAD+ synthesis by oncogenic URI causes liver tumorigenesis through DNA damage KS Tummala, AL Gomes, M Yilmaz, O Graña, L Bakiri, I Ruppen, ... Cancer cell 26 (6), 826-839, 2014 | 196 | 2014 |
Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells KST Marta Brandt, Ana Teijeiro, Osvaldo Grana, Robert F. Schwabe, Cristian ... Cell Reports 19, 584-600, 2017 | 129 | 2017 |
Regulation of OGT by URI in response to glucose confers c-MYC-dependent survival mechanisms S Burén, AL Gomes, A Teijeiro, MA Fawal, M Yilmaz, KS Tummala, ... Cancer cell 30 (2), 290-307, 2016 | 85 | 2016 |
Mutant IDH inhibits IFNγ–TET2 signaling to promote immunoevasion and tumor maintenance in cholangiocarcinoma MJ Wu, L Shi, J Dubrot, J Merritt, V Vijay, TY Wei, E Kessler, KE Olander, ... Cancer discovery 12 (3), 812-835, 2022 | 55 | 2022 |
mTORC1 inactivation promotes colitis-induced colorectal cancer but protects from APC loss-dependent tumorigenesis M Brandt, TP Grazioso, MA Fawal, KS Tummala, R Torres-Ruiz, ... Cell Metabolism 27 (1), 118-135. e8, 2018 | 44 | 2018 |
ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer H Ozturk, H Cingoz, T Tufan, J Yang, SJ Adair, KS Tummala, C Kuscu, ... Developmental Cell 57 (11), 1331-1346. e9, 2022 | 13 | 2022 |
NRF2: translating the redox code KS Tummala, F Kottakis, N Bardeesy Trends in molecular medicine 22 (10), 829-831, 2016 | 9 | 2016 |
Oncogene-induced NAD+ depletion in tumorigenesis KS Tummala, N Djouder Oncoscience 2 (4), 318, 2015 | 5 | 2015 |
ISL2 is an epigenetically silenced tumor suppressor and regulator of metabolism in pancreatic cancer T Tufan, J Yang, KS Tummala, H Cingoz, C Kuscu, SJ Adair, G Comertpay, ... bioRxiv, 2020.05. 23.112839, 2020 | 1 | 2020 |
Methods for Treating Cancer N Djouder, KS Tummala US Patent App. 15/500,199, 2017 | 1 | 2017 |
[14C]-Tryptophan Metabolic Tracing in Liver Cancer Cells KS Tummala, N Djouder bio-protocol 5 (17), 2015 | 1 | 2015 |
AGENTS FOR USE IN TREATING LIVER AND PANCREATIC CANCER KST Nabil Djouder EP Patent WO 2016/016391 A1, 2016 | | 2016 |
URI GENERATES METABOLIC ALTERATIONS-DEPENDENT DNA DAMAGE INDUCING HETEROGENEOUS LIVER TUMOURS KS Tummala, AL Gomes, IM Ruppen, L Bakiri, RC Olivas, O Graña, ... Journal of Hepatology 58, S447-S448, 2013 | | 2013 |
URI HEPATOCYTE-SPECIFIC OVEREXPRESSION IS SUFFICIENT TO INDUCE NON ALCOHOLIC STEATOHEPATITIS (NASH) A Gomes, K Tummala, N Djouder Journal of Hepatology 58, S510, 2013 | | 2013 |